The NLRP3 inflammasome: a therapeutic target of phytochemicals in treating atherosclerosis (a systematic review)
Atherosclerosis (AS) is a chronic inflammatory disease characterized by the gradual accumulation of plaques in arterial walls, with its pathogenesis remaining incompletely understood. Recent studies have highlighted that development of AS is closely associated with the aberrant activation of the NLR...
Saved in:
| Main Authors: | Yongchao Liu, Qianyi Wu, Jing Shao, Youmin Mei, Jie Zhang, Qiuyun Xu, Liming Mao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1568722/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NLRP3 inflammasome as a therapeutic target in doxorubicin-induced cardiotoxicity: role of phytochemicals
by: Xiao-Peng Zhao, et al.
Published: (2025-04-01) -
Pulmonary fibrosis through the prism of NLRP3 inflammasome: mechanistic pathways and prospective therapeutic innovations
by: Mengxue Wang, et al.
Published: (2025-05-01) -
Compound K Promotes Megakaryocytic Differentiation by NLRP3 Inflammasome Activation
by: Seonhwa Hwang, et al.
Published: (2024-10-01) -
NLRP11 is required for canonical NLRP3 and non-canonical inflammasome activation during human macrophage infection with mycobacteria
by: Mateusz Szczerba, et al.
Published: (2025-05-01) -
Understanding the Role of NLRP3 Inflammasome in Acute Pancreatitis
by: Konstantinos Papantoniou, et al.
Published: (2024-11-01)